Molecular cloning and expression of a rat Via arginine vasopressin receptor
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The neurohypophyseal hormone arginine vasopressin has diverse actions, including the inhibition of diuresis, contraction of smooth muscle, stimulation of liver glycogenolysis and modulation of adrenocorticotropic hormone release from the pituitary. Arginine vasopressin receptors are G protein-coupled and have been divided into at least three types; the V1a (vascular/hepatic) and V1b (anterior pituitary) receptors which act through phosphatidylinositol hydrolysis to mobilize intracellular Ca2+, and the V2 (kidney) receptor which is coupled to adenylate cyclase. We report here the cloning of a complementary DNA encoding the hepatic V1a arginine vasopressin receptor. The liver cDNA encodes a protein with seven putative transmembrane domains, which binds arginine vasopressin and related compounds with affinities similar to the native rat V1a receptor. The messenger RNA corresponding to the cDNA is distributed in rat tissues known to contain V1a receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One is impaired intracellular glucose metabolism due to increased gluconeogenesis and/or increased glycogenolysis as suggested by acute experiments [31,32], an effect probably related to V1aR activation [29].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [29]
Citations
Cites
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Self-citationCompilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
Cloning and expression of a cDNA encoding an endothelin receptor
Arai, H., Hori, S., Aramori, I., Ohkubo, H., & Nakanishi, S. (1990) · Nature · doi:10.1038/348730a0 · Cited by 2,578
Cloning and expression of a rat D2 dopamine receptor cDNA
Bunzow, J. R., Tol, H. H. M. V., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C. A., Neve, K. A., & Civelli, O. (1988) · Nature · doi:10.1038/336783a0 · Cited by 1,117
Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965
Repetitive transient rises in cytoplasmic free calcium in hormone-stimulated hepatocytes
Woods, N. M., Cuthbertson, K. S. R., & Cobbold, P. H. (1986) · Nature · doi:10.1038/319600a0 · Cited by 793
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 684
Structure and expression of a human oxytocin receptor
Kimura, T., Tanizawa, O., Mori, K., Brownstein, M. J., & Okayama, H. (1992) · Nature · doi:10.1038/356526a0 · Cited by 632
Self-citationKobilka, B. K., Frielle, T., Collins, S., Yang-Feng, T., Kobilka, T. S., Francke, U., Lefkowitz, R. J., & Caron, M. G. (1987) · Nature · doi:10.1038/329075a0 · Cited by 515
Research works printed but not linked: 5
- Matsuguchi, H., Schmid, P. G., Gorden, F. J. & Johnson, A. K. Physiologist 23, 29–33 (1980).
- Clements, J. A. & Funder, J. W. Endocr. Rev. 116, 416–423 (1986).
- Butlen, D. et al. Molec. Pharmac. 14, 1006–1017 (1978).
- Kozak, M. Nucleic Acids Res. 12, 857–872 (1984). · DOI · Paper page
- Bunzow, J. R. et al. Nature 336, 783–787 (1988). · DOI · Paper page
Cited by
Items 301–400 of 482
Putative Physiological Significance of Vasopressin V 1a Receptor Activation in Rat Pituicytes
Rosso, L., Maison-Peteri, B., & Mienville, J. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.0953-8194.2004.01160.x · Cited by 15
Neurohypophysial hormone receptors and second messengers in trout hepatocytes
Guibbolini, M. E., Pierson, P. M., & Lahlou, B. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670137 · Cited by 16
North, W. G., Fay, M. J., Longo, K. A., & Du, J. (1997) · Peptides · doi:10.1016/s0196-9781(97)00072-7 · Cited by 15
WANG, J., Hodges, R. S., & Sykes, B. D. (1995) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1995.tb01063.x · Cited by 15
Neurohypophyseal peptides as regulators of growth and development: A Review
Carter, D., Chooi, K. F., & Murphy, D. (1993) · Journal of Molecular Neuroscience · doi:10.1007/bf02736686 · Cited by 15
Klingler, C., Ancellin, N., Barrault, M., Morel, A., & Corman, B. (1998) · Biochemical Journal · doi:10.1042/bj3301023 · Cited by 15
Self-citationInhibition of vasopressin action in vascular smooth muscle by the V1 antagonist OPC-21268.
Li, X., Kribben, A., Wieder, E., Tsai, P., Nemenoff, R. A., & Schrier, R. W. (1994) · Hypertension · doi:10.1161/01.hyp.23.2.217 · Cited by 15
Vasopressin in the mammalian brain: The neurobiology of a mnemonic peptide
Brinton, R. D. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61570-8 · Cited by 16
Vasopressin V1A receptor mediates cell proliferation through GRK2-EGFR-ERK1/2 pathway in A7r5 cells
Zhang, L., Wang, X., Cao, H. W., Chen, Y., Chen, X., Zhao, X. W., Xu, F., Wang, Y., Woo, A. Y., & Zhu, W. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.10.023 · Cited by 14
Pharmacological characterization of YM471, a novel potent vasopressin V1A and V2 receptor antagonist
Tsukada, J., Tahara, A., Tomura, Y., Wada, K., Kusayama, T., Ishii, N., Aoki, M., Yatsu, T., Uchida, W., Taniguchi, N., et al. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01813-7 · Cited by 14
Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor gene
Watters, J. J., Swank, M. W., Wilkinson, C. W., & Dorsa, D. M. (1996) · Peptides · doi:10.1016/0196-9781(95)02085-3 · Cited by 14
Molecular Evolution of Ligand‐Binding Specificity in the Vasopressin/Oxytocin Receptor Familya
van Kesteren, R. E., & Geraerts, W. P. M. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10728.x · Cited by 14
Vasopressin-stimulated Ca2+spiking in vascular smooth muscle cells involves phospholipase D
Li, Y., Shiels, A. J., Maszak, G., & Byron, K. L. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.6.h2658 · Cited by 14
Diabètes insipides néphrogéniques
Bichet, D. G., & Zellweger, M. (2004) · Encyclopédie médico-chirurgicale. Néphrologie · doi:10.1016/j.emcnep.2003.11.001 · Cited by 14
Vasopressin in circadian function of SCN
Reghunandanan, V. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00109-3 · Cited by 13
Clerget-Froidevaux, M.-S., Elalouf, J., & Germain, G. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00218-9 · Cited by 16
Hormonal and local regulation of uterine activity during parturition: part I — The oxytocin system
Maggi, M., Baldi, E., & Susini, T. (1994) · Journal of Endocrinological Investigation · doi:10.1007/bf03347771 · Cited by 17
Comparison of vasopressin and oxytocin receptors in the rat uterus and vascular tissue
Anouar, A., Clerget-Froidevaux, M.-S., Durroux, T., Barberis, C., & Germain, G. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00258-0 · Cited by 13
Structure and Sequence of the Mouse V1a and V1b Vasopressin Receptor Genes.
Kikuchi, S., Tanoue, A., Goda, N., Matsuo, N., & Tsujimoto, G. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.81.388 · Cited by 13
Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms
Andrés, M., Peña, A., Derick, S., Raufaste, D., Trojnar, J., Wiśniewski, K., Trueba, M., Gal, C. S., & Guillon, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.026 · Cited by 13
Vasopressin V1a receptor is required for nucleocytoplasmic transport of mineralocorticoid receptor
Hori, K., Nagai, T., Izumi, Y., Kimura, M., Hasuike, Y., Nakayama, Y., Nanami, M., Tokuyama, M., Otaki, Y., Kuragano, T., et al. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00052.2012 · Cited by 14
Pharmacological characterization of a novel AVP4–9 binding site in rat hippocampus
Nakayama, Y., Takano, Y., Shimohigashi, Y., Tanabe, S., Fujita, T., Kamiya, H., & Tsujimoto, G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01955-7 · Cited by 13
Migita, K., Hori, N., Manako, J.-I., Saito, R., Takano, Y., & Kamiya, H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00753-8 · Cited by 13
Vasopressin receptors and effects during fetal development
Ervin, M. G., Kullama, L. K., Ross, M. G., Leake, R. D., & Fisher, D. A. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90207-o · Cited by 13
Tahara, A., Tsukada, J., Ishii, N., Tomura, Y., Wada, K., Kusayama, T., Yatsu, T., Uchida, W., & Tanaka, A. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00059-2 · Cited by 13
Ramcharan, E. J., & Matthews, M. R. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00478-5 · Cited by 13
Chapter 27 The vasopressin receptor of corticotroph pituitary cells
René, P., & de Keyzer, Y. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39029-0 · Cited by 15
Toba, K., Ouchi, Y., Liang, J., Akishita, M., & Orimo, H. (1994) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(94)90002-7 · Cited by 12
Howl, J., Procházka, Z., Wheatley, M., & Slaninová, J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702857 · Cited by 13
Molecular cloning of a human oxytocin receptor
Kimura, T., Azuma, C., Takemura, M., Inoue, T., Kikuchi, T., Kubota, Y., Ogita, K., Saji, F., & Tanizawa, O. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90185-b · Cited by 12
Carnazzi, E., Aumelas, A., Phalipou, S., Mouillac, B., Guillon, G., Barberis, C., & Seyer, R. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00906.x · Cited by 12
Molecular cloning and sequencing of the gene encoding a sheep arginine vasopressin type 1a receptor
Hutchins, A., Phillips, P. A., Venter, D. J., Burrell, L. M., & Johnston, C. I. (1995) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(95)00125-z · Cited by 12
Characterization of G Protein-Coupled Receptors Expressed by ECV304 Human Endothelial Cells
Howl, J., Mondszein, R. M., & Wheatley, M. (1998) · Endothelium · doi:10.3109/10623329809053402 · Cited by 16
Vasopressin and a Nonpeptide Antidiuretic Hormone Receptor Antagonist (OPC-31260)
Burrell, L. M., Phillips, P. A., Stephenson, J. M., Risvanis, J., & Johnston, C. I. (1994) · Blood Pressure · doi:10.3109/08037059409101533 · Cited by 12
Contreras‐Romo, M. C., Martínez‐Archundia, M., Deeb, O., Ślusarz, M. J., Ramírez-Salinas, G. L., Garduño‐Juárez, R., Quintanar‐Stephano, A., Ramírez‐Galicia, G., & Correa‐Basurto, J. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12229 · Cited by 11
Chen, S., Webber, M. J., Vilardaga, J., Khatri, A., Brown, D., Ausiello, D. A., Lin, H. Y.-F., & Bouley, R. (2011) · Endocrinology · doi:10.1210/en.2011-1049 · Cited by 11
Robertson, G. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00042-2 · Cited by 11
Conformational selection of vasopressin upon V 1a receptor binding
Che, K., Muttenthaler, M., & Kurzbach, D. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.10.024 · Cited by 11
Tran, D., Durroux, T., Stelly, N., Seyer, R., Tordjmann, T., Combettes, L., & Claret, M. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700314 · Cited by 11
Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat
Hansen, F. H., Vågnes, Ø. B., & Iversen, B. M. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00175.2004 · Cited by 11
Guillon, G., Peña, A., Murat, B., Derick, S., Trueba, M., Ventura, M. A., Szeto, H. H., Wo, N. C., Stoev, S. B., Cheng, L., et al. (2005) · Journal of Peptide Science · doi:10.1002/psc.710 · Cited by 11
Disorders of the Posterior Pituitary
Muglia, L. J., & Majzoub, J. A. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50014-4 · Cited by 13
Process Formation in Astrocytes: Modulation of Cytoskeletal Proteins
Padmanabhan, J., & Shelanski, M. L. (1998) · Neurochemical Research · doi:10.1023/a:1022413718447 · Cited by 11
Structure and function of neurohypophysial hormone receptors
Wheatley, M., Howl, J., YARWOOD, N. J., Hawtin, S. R., Davies, A. R. L., Matthews, G. M., & Parslow, R. A. (1997) · Biochemical Society Transactions · doi:10.1042/bst0251046 · Cited by 11
Vasopressin receptor-mediated endocytosis in cells transfected with V1-type vasopressin receptors
Lutz, W. H., Sanders, M., Salisbury, J. L., Lolait, S. J., O’Carroll, A., & Kumar, R. (1993) · Kidney International · doi:10.1038/ki.1993.119 · Cited by 11
Self-citationMechanism of AVP release and synthesis in chronic salt-loaded rats
Morita, M., Kita, Y., & Notsu, Y. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011778106 · Cited by 11
Easaw, J. C., Jassar, B. S., & Jhamandas, J. H. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00159-0 · Cited by 11
Mendre, C., Dufour, M. N., Roux, S. L., Seyer, R., Guillou, L., Calas, B., & Guillon, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21027 · Cited by 11
Lewis, S. J., Hoque, A., Sandock, K., Robertson, T. P., Bates, J. N., & Kooy, N. W. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.06.004 · Cited by 10
Paudel, P., Kim, D. H., Jeon, J., Park, S. E., Seong, S. H., Jung, H. A., & Choi, J. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073335 · Cited by 10
Identification of a Novel V1-type AVP Receptor Based on the Molecular Recognition Theory
Herrera, V. L. M., & Ruiz‐Opazo, N. (2001) · Molecular Medicine · doi:10.1007/bf03401855 · Cited by 10
Kolaj, M., & Renaud, L. P. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61575-7 · Cited by 9
Disorders of the posterior pituitary
Muglia, L. J., Srivatsa, A., & Majzoub, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00020-2 · Cited by 11
Dou, D., Chen, L., Di, H., Song, Z.-R., Li, S., Bu, X., Dai, Q., Wang, S., Li, J. X., Zhu, X., et al. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13493 · Cited by 12
Altered cardiovascular regulation in arginine vasopressin-overexpressing transgenic rat
Tachikawa, K., Yokoi, H., Nagasaki, H., Arima, H., Murase, T., Sugimura, Y., Miura, Y., Hirabayashi, M., & Oiso, Y. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00570.2002 · Cited by 10
Lack of Interaction of Vasopressin with its Antisense Peptides: A Functional and Immunological Study
Jurzak, M., Pavo, I. J., & Fahrenholz, F. (1993) · Journal of Receptor Research · doi:10.3109/10799899309073699 · Cited by 10
Toward peptide receptor ligand drugs: Progress on nonpeptides
Freidinger, R. M. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7147-1_4 · Cited by 10
Yamaguchi, Y., Maekawa, Y., Kabashima, K., Mizuno, T., Tainaka, M., Suzuki, T., Dojo, K., Tominaga, T., Kuroiwa, S., Masubuchi, S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308489120 · Cited by 13
Szczepanska‐Sadowska, E. K., Cudnoch‐Jędrzejewska, A., & Żera, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413307 · Cited by 11
Powell-Roach, K. L., Hershberger, P. E., Rutherford, J. N., Molokie, R. E., Wang, Z. J., & Wilkie, D. J. (2018) · Pain Management Nursing · doi:10.1016/j.pmn.2018.01.003 · Cited by 9
Structures of the arginine-vasopressin and oxytocin receptor signaling complexes
Bous, J., Fouillen, A., Orcel, H., Granier, S., Bron, P., & Mouillac, B. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2022.12.003 · Cited by 9
Ślusarz, M. J., Sikorska, E., & Ślusarz, R. (2013) · Journal of Peptide Science · doi:10.1002/psc.2485 · Cited by 11
Anti-edematous Effects of Tolvaptan in Experimental Rodent Models
Miyazaki, T., Sakamoto, Y., Yamashita, T., Ohmoto, K., & Fujiki, H. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6355-z · Cited by 10
Autoimmune Central Diabetes Insipidus
Bellastella, A., Bizzarro, A., & Bellis, A. D. (2004) · Informa Healthcare eBooks · doi:10.1201/9780203021941.ch22 · Cited by 9
Birnbaumer, M. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50060-3 · Cited by 9
Molecular Biology of Peptide and Glycoprotein Hormone Receptors
Poyner, D. R., & Hanley, M. R. (1992) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-6772-7_9 · Cited by 9
AVP V1a-R expression in the rat hypothalamus around parturition: relevance to antipyresis at term
Clerget-Froidevaux, M.-S., & Pittman, Q. J. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00114-6 · Cited by 9
Homology between neurohypophyseal hormone receptors
Wheatley, M., Howl, J., Morel, A., & Davies, A. R. L. (1993) · Biochemical Journal · doi:10.1042/bj2960519 · Cited by 9
Self-citationVasopressin V1a and V2 Receptor mRNA in Deoxycorticosterone Acetate-Salt Hypertension in the Rat
Risvanis, J., Johnston, C. I., Phillips, P. A., & Burrell, L. M. (1998) · Clinical Science · doi:10.1042/cs0940517 · Cited by 9
Arakawa, H., & Higuchi, Y. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104597 · Cited by 8
Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Bichet, D. G., Bouvier, M., Chini, B., Gimpl, G., Guillon, G., Kimura, T., Knepper, M. A., Lolait, S. J., Manning, M., Mouillac, B., et al. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f66/2019.4 · Cited by 9
Self-citationShinoura, H., Take, H., Hirasawa, A., Inoue, K., Ohno, Y., Hashimoto, K., & Tsujimoto, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01079-6 · Cited by 8
Expression cloning of the human V2 vasopressin receptor
Barberis, C., Seibold, A. M., Ishido, M., Rosenthal, W., & Birnbaumer, M. E. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90183-9 · Cited by 8
Sandnes, D., Dajani, O. F., Bjørneby, A., & Christoffersen, T. (1999) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1999.tb01488.x · Cited by 8
Identification of Arginine Vasopressin mRNA in Rat Aortic Smooth Muscle Cells
Nagano, K., Toba, K., Akishita, M., Kozaki, K., Eto, M., Hashimoto, M., Sudoh, N., Yoshizumi, M., & Ouchi, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6102 · Cited by 8
Role of Vasopressin in Central Cardiovascular Regulation
Berecek, K. H. (1992) · Central Neural Mechanisms in Cardiovascular Regulation · doi:10.1007/978-1-4684-9184-5_1 · Cited by 8
Kusaka, I., Ishikawa, S., Higashiyama, M., Saito, T., Nagasaka, S., & Saito, T. (1996) · Endocrinology · doi:10.1210/endo.137.12.8940366 · Cited by 8
Haider, A., Xiao, Z., Xia, X., Chen, J., Van, R. S., Kuang, S., Zhao, C., Rong, J., Shao, T., Ramesh, P., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105886 · Cited by 7
Meyerhof, W., Darlison, M. G., & Richter, D. (1993) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60366-x · Cited by 7
Vagnes, Ø. B., Hansen, F. H., Feng, J. J., Iversen, B. M., & Arendshorst, W. J. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00363.2004 · Cited by 7
Koukoulas, I., Webb, G. C., Bottema, C. D. K., Gill, C. A., Johnston, C. I., & Aldred, G. P. (1999) · Gene · doi:10.1016/s0378-1119(99)00407-2 · Cited by 7
Vågnes, Ø. B., Hansen, F. H., Christiansen, R. E. F., Gjerstad, C., & Iversen, B. M. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00399.2003 · Cited by 7
Up-regulation of vasopressin V1a receptor mRNA in rat facial motoneurons following axotomy
Chritin, M., Roquette, P., Schulz, M. F., Breton, C., & Tribollet, E. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00148-5 · Cited by 7
Tahara, A., Tsukada, J., Tomura, Y., Kusayama, T., Wada, K., Ishii, N., Yatsu, T., Uchida, W., Taniguchi, N., & Tanaka, A. (2002) · Journal of Hypertension · doi:10.1097/00004872-200209000-00026 · Cited by 7
Nephrogenic Diabetes Insipidus and Vasopressin Receptor Mutations
Bichet, D. G. (1998) · Humana Press eBooks · doi:10.1007/978-1-4612-1802-9_10 · Cited by 7
Montero, S., Yarkov, A., Lemus, M., de Álvarez-Buylla, E. R., & Álvarez-Buylla, R. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.03.001 · Cited by 7
Molecular Biology and Gene Regulation of Vasopressin
Tiwari, S., & ECELBARGER, C. A. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373870-7.00017-x · Cited by 6
Effect of N-Glycosylation on Ligand Binding Affinity of Rat V1a Vasopressin Receptor
Lee, K.-H., Ahn, J.-I., Yu, D., Jeong, H., Lee, S., Kim, K., Chung, I., Kim, J.-H., & Lee, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5456 · Cited by 6
Tolvaptan for the Treatment of Hyponatremia and Congestive Heart Failure
Orlandi, C., Zimmer, C. A., & Gheorghiade, M. (2006) · Future Cardiology · doi:10.2217/14796678.2.6.627 · Cited by 6
Ponthieux, S., Cabot, J., Mouillac, B., Seyer, R., Barberis, C., & Carnazzi, E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040871+ · Cited by 6
Synthesis and pharmacological profile of non-peptide vasopressin antagonists
Galanski, M. E., Erker, T., Studenik, C. R., Kamyar, M.-R., Rawnduzi, P., Pabstova, M., & Lemmens‐Gruber, R. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.12.008 · Cited by 6
Vasopressin V1a and V1b receptor modulators: a patent review (2012 – 2014)
Ślusarz, M. J. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1026257 · Cited by 7
Vasopressin regulation of cell growth in Swiss 3T3 cells
Zachary, I. C., Sinnett‐Smith, J. W., & Rozengurt, E. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90211-p · Cited by 6
Auld, A. M., Bawden, M. J., Berven, L. A., Harland, L. M., Hughes, B. P., & Barritt, G. J. (1996) · Cell Calcium · doi:10.1016/s0143-4160(96)90117-7 · Cited by 6
Defining the ligand-binding site for vasopressin receptors: a peptide mimetic approach
Howl, J., Parslow, R. A., & Wheatley, M. (1995) · Biochemical Society Transactions · doi:10.1042/bst0230103 · Cited by 6
Borrow, A. P., Stover, S. A., Bales, N. J., & Handa, R. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00010-9 · Cited by 5
Structure and Sequence of the Mouse Vla and Vlb Vasopressin Receptor Genes
Kikuchi, S., Tanoue, A., Goda, N., Matsuo, N., & Tsujimoto, G. (1999) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)30751-6 · Cited by 5
Vasoactive Peptides and Their Receptors
Regoli, D. C., Cadieux, A., & D’Orléans-Juste, P. (1993) · Methods in neurosciences · doi:10.1016/b978-0-12-185271-9.50009-5 · Cited by 5
Regulation of APP Processing by First Messengers
Nitsch, R. M., Growdon, J. H., Farber, S. A., Deng, M., & Wurtman, R. J. (1994) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-8149-9_9 · Cited by 5
The Dual Role of Thymic Neurohypophysial‐Related Self Peptides in T Cell Selection
Geenen, V. G., Martens, H., ROBERT, F., Benhida, A., Cormann-Goffin, N., Legros, J., MARTIAL, J. A., & Franchimont, P. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb55557.x · Cited by 5
Metadata
- Authors
- Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Morel, Alain
- Venue
- Nature
- Published
- 1992-04
- Volume
- 356
- Issue
- 6369
- Pages
- 523-526
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2007060613
- Semantic Scholar
- e3358299b468c8f7ee7c12e49293b5113bd0ce45
- Cited by
- 477
- References
- 29
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 1 · 2019: 7 · 2018: 4 · 2017: 3 · 2016: 9 · 2015: 4 · 2014: 7 · 2013: 11 · 2012: 9
- FWCI
- 80.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- arginine vasopressin receptor, V1a receptor, G protein-coupled receptors, cDNA cloning, rats, receptor structure, transmembrane domain, ligand binding affinity, mRNA distribution, liver glycogenolysis, diuresis
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cloning, Molecular, Dose-Response Relationship, Drug, Female, Cricetinae, Kidney, Liver, Molecular Sequence Data, Ovary, Receptors, Angiotensin, Recombinant Proteins, RNA, Messenger, Sequence Homology, Nucleic Acid, Spleen, Xenopus, Blotting, Northern, Gene Library, Receptors, Vasopressin, GTP-Binding Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.